The evolution of cancer risk assessment in the era of next generation sequencing.

doi:10.1007/s10897-014-9714-7

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

The evolution of cancer risk assessment in the era of next generation sequencing.

Journal of genetic counseling - 1 Aug 2014

Fecteau Heather, Vogel Kristen J, Hanson Kristen, Morrill-Cornelius Shannon

Abstract excerpt

Cancer genetics professionals face a new opportunity and challenge in adapting to the availability of cancer genetic testing panels, now available as a result of Next Generation Sequencing (NGS) technology. While cancer panels have been available for over a year, we believe that there is not yet enough data to create practice guidelines. Despite this, a year of experience allows us to provide our opinion on...

Topics

Genetic Counseling
Genetic Predisposition to Disease
Genetic Testing
Humans
Informed Consent
Neoplasms
Risk Assessment
Sequence Analysis

Source

Open in PubMed

Identifiers

PMID: 24756768
DOI: 10.1007/s10897-014-9714-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics